Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • Attovia files for IPO to take on Sanofi and Regeneron’s Dupixent

Attovia files for IPO to take on Sanofi and Regeneron’s Dupixent

  • July 15, 2026

Attovia Therapeutics has filed for an IPO to secure funding for assets including a potential challenger to Sanofi and Regeneron’s Dupixent and Galderma’s Nemluvio.

Leave A Comment

Fields (*) Mark are Required